Cutting edge: TGF-β-induced expression of Foxp3 in T cells is mediated through inactivation of ERK

Journal of Immunology

Volumn 180, Issue 5, 2008, Pages 2757-2761

  Luo, Xunrong ^a,b   Zhang, Qiang ^a   Liu, Victoria ^a   Xia, Zhenbiao ^a   Pothoven, Kathryn L ^a   Lee, Chung ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Tarry Building 11 723 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA METHYLTRANSFERASE; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UO 126; DNA (CYTOSINE 5 ) METHYLTRANSFERASE 1; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; LYMPHOCYTE ANTIGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DEMETHYLATION; DOWN REGULATION; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; EPIGENETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL CULTURE; CELL CYCLE G0 PHASE; DNA METHYLATION; DRUG ANTAGONISM; ENZYME ACTIVATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; NONOBESE DIABETIC MOUSE; PHOSPHORYLATION; PHYSIOLOGY; REGULATORY T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; CELLS, CULTURED; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DOWN-REGULATION; ENZYME ACTIVATION; FORKHEAD TRANSCRIPTION FACTORS; G0 PHASE; GENE EXPRESSION REGULATION; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA1;

EID: 49149089989     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.5.2757     Document Type: Article

References (27)

1. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155: 1151-1164.
2. - thymocytes. J. Exp. Med. 189: 279-288.
3. + T cells. J. Autoimmun. 16: 115-123.
4. Fontenot, J. D., J. P. Rasmussen, L. M. Williams, J. L. Dooley, A. G. Farr, and A. Y. Rudensky. 2005. Regulatory T cell lineage specification by the Forkhead transcription factor foxp3. Immunity 22: 329-341.
5. Bluestone, J. A., and A. K. Abbas. 2003. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3: 253-257.
6. + regulatory T cells. Immunology 109: 319-325.
7. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
8. + regulatory T cells. Proc. Natl. Acad. Sci. USA 104: 2821-2826.
9. + T regulatory cells: role of tumor-derived TGF-β. J. Immunol. 178: 2883-2892.
10. Selvaraj, R. K., and T. L. Geiger. 2007. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-β. J. Immunol. 179: 178: 7667-7677.
11. Floess, S., J. Freyer, C. Siewert, U. Baron, S. Olek, J. Polansky, K. Schlawe, H. D. Chang, T. Bopp, E. Schmitt, et al. 2007. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5: e38.
12. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
13. Attwood, J., and B. Richardson. 2004. Relative quantitation of DNA methyltransferase mRNA by real-time RT-PCR assay. Methods Mol. Biol. 287: 273-283.
14. Mulder, K. M. 2000. Role of Ras and MAPKs in TGFβ signaling. Cytokine Growth Factor Rev. 11: 23-35.
15. Javelaud, D., and A. Mauviel. 2005. cross-talk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-β: implications for carcinogenesis. Oncogene 24: 5742-5750.
16. Zhang, M., D. Fraser, and A. Phillips. 2006. ERK, p38, and Smad signaling pathways differentially regulate transforming growth factor-β1 autoinduction in proximal tubular epithelial cells. Am. J. Pathol. 169: 1282-1293.
17. Giehl, K., B. Seidel, P. Gierschik, G. Adler, and A. Menke. 2000. TGFβ1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation. Oncogene 19: 4531-4541.
18. Saud, K., R. Herrera-Molina, and R. Von Bernhardi. 2005. Pro- and antiinflammatory cytokines regulate the ERK pathway: implication of the timing for the activation of microglial cells. Neurotox. Res. 8: 277-287.
19. Wisdom, R., L. Huynh, D. Hsia, and S. Kim. 2005. RAS and TGF-β exert antagonistic effects on extracellular matrix gene expression and fibroblast transformation. Oncogene 24: 7043-7054.
20. - precursors. Am J Transplant. 4: 1614-1627.
21. Deng, C., M. J. Kaplan, J. Yang, D. Ray, Z. Zhang, W. J. McCune, S. M. Hanash, and B. C. Richardson. 2001. Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum. 44: 397-407.
22. Oelke, K., and B. Richardson. 2004. Decreased T cell ERK pathway signaling may contribute to the development of lupus through effects on DNA methylation and gene expression. Int. Rev. Immunol. 23: 315-331.
23. Lu, R., X. Wang, Z. F. Chen, D. F. Sun, X. Q. Tian, and J. Y. Fang. 2007. Inhibition of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway decreases DNA methylation in colon cancer cells. J. Biol. Chem. 282: 12249-12259.
24. + regulatory T cell function via innate TLR2 signaling. J. Clin. Invest. 116: 2022-2032.
25. + regulatory T cells. J. Immunol. 177: 2186-2194.
26. Deng, C., Q. Lu, Z. Zhang, T. Rao, J. Attwood, R. Yung, and B. Richardson. 2003. Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. Arthritis Rheum. 48: 746-756.
27. Lu, Q., A. Wu, and B. C. Richardson. 2005. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs. J. Immunol. 174: 6212-6219.